何(柏)良:本港有足夠能力預防重症可放寬入境
港大感染及傳染病中心總監何(柏)良指出,根據本港整體自然感染和完成基本接種的人口,已有足夠能力預防重症,可以放寬入境檢疫安排。他在一個電臺節目提到,本港去年11月起纔開放予預約市民接種第三劑新冠疫苗,但只有很少人第一時間接種,而第四針須與第三針相隔6個月,相信合資格接種第四針的人不多,若接種復必泰疫苗,防重症成效在打針後半年仍相當高,認爲健康人士無迫切性打第四針。
中環九如坊蘭桂坊酒店先後有不同房間的檢疫住客確診,屬Omicron BA.2.12.1變異病毒株。港大感染及傳染病中心總監何(柏)良表示,過去一年本港斷續地有檢疫酒店內出現傳播,完全杜絕並不可能,籲市民要有心理準備會有個案走入社區,但關鍵不是相關個案數目,而是會否令社區內重症個案增加。
何(柏)良指,近期全球出現較大羣組猴痘感染,主要集中在歐洲和北美,尤其是英國,以暫時觀察所見,可能涉及皮膚緊密接觸,預計隨着相關檢測增加,歐洲本週的猴痘個案可能會明顯上升,一至兩各星期後才見頂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.